Francisco Ujueta/LinkedIn;
Eric A Secemsky/LinkedIn
Apr 12, 2026, 13:44
Francisco Ujueta: PAD VS CAD – Why Individualized Antithrombotic Strategies Matter
Francisco Ujueta, Vascular Cardiologist at Vanderbilt University Medical Center, shared a post on LinkedIn about a recent article he and his colleague co-authored, adding:
“View our commentary on differences in PAD and CAD – emphasizing higher ischemic and bleeding risks, greater heterogeneity, and the need for individualized antithrombotic strategies.”
Title: Too much, too little, or just right: Tailoring postrevascularization antithrombotic therapy in PAD versus CAD when one size does not fit all
Authors: Francisco Ujueta, Eric A Secemsky
Read the Full Article on Vascular Medicine
Stay updated with Hemostasis Today.
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early
-
May 28, 2026, 09:15Alejandro González Veliz: Why Cardiovascular Prevention Matters More Than Intervention
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires